Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Hypothesis:
There is likelihood of significant symptoms of depression and anxiety among general population in India during the current COVID-19 outbreak.
Procedure:
The participants would be selected with their informed consent. The objective of the study would be clearly written on Page 1 of the survey. The test would be administered electronically by all the participants individually only when consented to the study. The data collected will be kept strictly confidential and the identity of the participants will not be disclosed at any point of the research
Measures:
Aim:
Hypothesis:
There is likelihood of significant symptoms of depression and anxiety among general population in India during the current COVID-19 outbreak.
Procedure:
The participants would be selected with their informed consent. The objective of the study would be clearly written on Page 1 of the survey. The test would be administered electronically by all the participants individually only when consented to the study. The data collected will be kept strictly confidential and the identity of the participants will not be disclosed at any point of the research
Measures:
Primary outcome To understand the prevalence (magnitude) of depression and anxiety of general adult population during COVID-19 using Generalized Anxiety Disorder Scale (GAD-7) and Patient Health Questionnaire (PHQ-9). Rise in Anxiety and Depression will be noted.
Through the analysis of the results, help device psychological intervention/mental health programs geared towards general and specific symptoms and management of emotional needs can be provided to the general population during and post-crisis.
Secondary Outcome Through the analysis of the results, it will help device psychological intervention/mental health programs geared towards general and specific symptoms and management of emotional needs can be provided to the general population during and post-crisis.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Registery Data Collection | Behavioral | Observational Data Collection |
| Measure | Description | Time Frame |
|---|---|---|
| Prevalence (magnitude) of anxiety of general adult population during COVID-19 | To understand the prevalence (magnitude) of depression and anxiety of general adult population during COVID-19 using Generalized Anxiety Disorder Scale (GAD-7) | 1 YEAR |
| prevalence (magnitude) of depression and anxiety of general adult population during COVID 19 | To understand the prevalence (magnitude) of depression and anxiety of general adult population during COVID-19 using Patient Health Questionnaire (PHQ-9). | 1 Year |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Participants of the age of 18 years and above
Participants residing in India
Participants with minimum 10 years of education with basic knowledge of English
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Sameer Malhotra | Contact | 9891059770 | Sameer.Malhotra@maxhealthcare.com | |
| Shreya Singhal | Contact | 9810022980 | Sameer.Malhotra@maxhealthcare.com |
| Name | Affiliation | Role |
|---|---|---|
| Sameer Malhotra | max healthcare | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Max Super Speciality hospital | Recruiting | New Delhi | National Capital Territory of Delhi | 110017 | India |
Not provided
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
| D014777 |
| Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |